Jeffrey Alan Hubbell is an American molecular engineer. During his early career, Hubbell founded three companies based on his academic research and was the holder of 88 U.S. patents.
Upon completing his PhD, Hubbell joined the faculty at Switzerland's École Polytechnique Fédérale de Lausanne where he served as the founding director of the Institute of Bioengineering.[3] In 1995, Hubbell was elected a fellow of the American Institute for Medical and Biological Engineering for his "fundamental and clinically-applied contributions to biomaterials."[4] During his early career, he founded three companies based on his academic research and was the holder of 88 U.S. patents. Hubbell remained in Switzerland until 2014 when he accepted a position at the University of Chicago faculty of engineering as their Barry L. MacLean Professor for Molecular Engineering Innovation and Enterprise.[3] He was also elected a fellow of the National Academy of Inventors.[5]
Upon joining the University of Chicago, Hubbell collaborated with Cathryn Nagler to establish the ClostraBio, a company to develop drugs.[6] By 2017, Hubbel was the recipient of the Society for Biomaterials’ Founders Award for his "long-term, landmark contributions to the discipline of biomaterials." He was specifically recognized for designing materials to assemble and function so they could stimulate the immune system to fight infection or malignancy and coining the term "immuno-modulatory materials."[7] In the same year, Hubbel was awarded the Acta Biomaterialia Gold Medal[8] and appointed the inaugural Bell Professor in Tissue Engineering at the University of Chicago.[9]
In 2018, Hubbell was also elected a Member of the National Academy of Medicine for his work "pioneering the development of cell responsive (bioactive) materials and inventing biomaterials that are now widely utilized in regenerative medicine."[10] Following this, he helped develop a new system for delivering a malaria vaccine.[11]
During the COVID-19 pandemic, Hubbell and Melody Swartz co-launched the Chicago Immunoengineering Innovation Center to develop new technologies to treat diseases, including cancer, autoimmune disorders, and COVID-19. Throughout the pandemic, the researchers at the center began developing computational and experimental approaches to new vaccines and vaccine delivery methods.[12] In April 2020, Hubbell, Swartz, and Jun Ishihara co-published their research on an immunotherapy delivery system that finds tumors by seeking out and binding to the tumors’ collagen.[13] Following this development, he helped design a new therapy to assist those with multiple sclerosis by fusing a cytokine to a blood protein.[14] Later, in 2021, Hubbell was one of eight University of Chicago faculty members elected to the American Academy of Arts and Sciences.[15]
Personal lifeedit
Hubbell married speech pathologist Juliet Boege in 1983.[1]
^"Jeffrey Hubbell". University of Chicago. Retrieved June 11, 2021.
^ ab"UChicago faculty members receive named, distinguished service professorships". University of Chicago. November 11, 2014. Retrieved June 14, 2021.
^"JEFFREY HUBBELL, PH.D." American Institute for Medical and Biological Engineering. Retrieved June 14, 2021.
^"National Academy of Inventors announces 2014 NAI Fellows". National Academy of Inventors. 2014. Retrieved June 14, 2021.
^Reiter, Carla (October 27, 2016). "Scientist builds drug development company out of research lab". University of Chicago. Retrieved June 14, 2021.
^Borzo, Greg (May 9, 2017). "Jeffrey Hubbell honored for landmark biomaterials research". University of Chicago. Retrieved June 14, 2021.
^"Jeffrey Hubbell, recipient of the 2018 Acta Biomaterialia Gold Medal". Materials Today. November 3, 2017. Retrieved June 14, 2021.
^"Jeffrey Hubbell named inaugural Bell Professor in Tissue Engineering". University of Chicago. June 15, 2017. Retrieved June 14, 2021.
^"Jeffrey Hubbell named to National Academy of Medicine". University of Chicago. October 19, 2018. Retrieved June 14, 2021.
^Ayshford, Emily (February 1, 2019). "New vaccine for malaria developed at IME could be more effective". University of Chicago. Retrieved June 14, 2021.
^"Chicago Immunoengineering Innovation Center launches to develop technologies to treat diseases". University of Chicago. April 22, 2020. Retrieved June 14, 2021.
^Ayshford, Emily (April 30, 2020). "Breakthrough helps fight 'cold' tumors that don't respond to immunotherapy". University of Chicago. Retrieved June 14, 2021.
^Ayshford, Emily (October 12, 2020). "UChicago researchers find way to improve multiple sclerosis treatment". University of Chicago. Retrieved June 14, 2021.
^"Eight UChicago faculty elected to American Academy of Arts and Sciences". University of Chicago. April 23, 2021. Retrieved June 14, 2021.
jeffrey, hubbell, jeffrey, alan, hubbell, american, molecular, engineer, during, early, career, hubbell, founded, three, companies, based, academic, research, holder, patents, bornoverland, park, kansas, usspousejuliet, boege, 1983, academic, backgroundeducati. Jeffrey Alan Hubbell is an American molecular engineer During his early career Hubbell founded three companies based on his academic research and was the holder of 88 U S patents Jeffrey HubbellBornOverland Park Kansas USSpouseJuliet Boege m 1983 wbr Academic backgroundEducationBSc chemical engineering 1982 Kansas State UniversityPhD chemical engineering 1986 Rice UniversityThesisVisualization and Analysis of Mural Thrombogenesis Platelet Adhesion Collagen Polyurethane Digital Image Processing 1986 Academic workInstitutionsUniversity of ChicagoEcole Polytechnique Federale de LausanneNotable studentsDavid Scott Wilson Contents 1 Early life and education 2 Career 3 Personal life 4 References 5 External linksEarly life and education editHubbell was born to father Ron Hubbell in Overland Park Kansas 1 He received his bachelor s degree from Kansas State University and his PhD from Rice University in chemical engineering 2 Career editUpon completing his PhD Hubbell joined the faculty at Switzerland s Ecole Polytechnique Federale de Lausanne where he served as the founding director of the Institute of Bioengineering 3 In 1995 Hubbell was elected a fellow of the American Institute for Medical and Biological Engineering for his fundamental and clinically applied contributions to biomaterials 4 During his early career he founded three companies based on his academic research and was the holder of 88 U S patents Hubbell remained in Switzerland until 2014 when he accepted a position at the University of Chicago faculty of engineering as their Barry L MacLean Professor for Molecular Engineering Innovation and Enterprise 3 He was also elected a fellow of the National Academy of Inventors 5 Upon joining the University of Chicago Hubbell collaborated with Cathryn Nagler to establish the ClostraBio a company to develop drugs 6 By 2017 Hubbel was the recipient of the Society for Biomaterials Founders Award for his long term landmark contributions to the discipline of biomaterials He was specifically recognized for designing materials to assemble and function so they could stimulate the immune system to fight infection or malignancy and coining the term immuno modulatory materials 7 In the same year Hubbel was awarded the Acta Biomaterialia Gold Medal 8 and appointed the inaugural Bell Professor in Tissue Engineering at the University of Chicago 9 In 2018 Hubbell was also elected a Member of the National Academy of Medicine for his work pioneering the development of cell responsive bioactive materials and inventing biomaterials that are now widely utilized in regenerative medicine 10 Following this he helped develop a new system for delivering a malaria vaccine 11 During the COVID 19 pandemic Hubbell and Melody Swartz co launched the Chicago Immunoengineering Innovation Center to develop new technologies to treat diseases including cancer autoimmune disorders and COVID 19 Throughout the pandemic the researchers at the center began developing computational and experimental approaches to new vaccines and vaccine delivery methods 12 In April 2020 Hubbell Swartz and Jun Ishihara co published their research on an immunotherapy delivery system that finds tumors by seeking out and binding to the tumors collagen 13 Following this development he helped design a new therapy to assist those with multiple sclerosis by fusing a cytokine to a blood protein 14 Later in 2021 Hubbell was one of eight University of Chicago faculty members elected to the American Academy of Arts and Sciences 15 Personal life editHubbell married speech pathologist Juliet Boege in 1983 1 References edit a b Boege Hubbell The Manhattan Mercury June 19 1983 Retrieved June 11 2021 Jeffrey Hubbell University of Chicago Retrieved June 11 2021 a b UChicago faculty members receive named distinguished service professorships University of Chicago November 11 2014 Retrieved June 14 2021 JEFFREY HUBBELL PH D American Institute for Medical and Biological Engineering Retrieved June 14 2021 National Academy of Inventors announces 2014 NAI Fellows National Academy of Inventors 2014 Retrieved June 14 2021 Reiter Carla October 27 2016 Scientist builds drug development company out of research lab University of Chicago Retrieved June 14 2021 Borzo Greg May 9 2017 Jeffrey Hubbell honored for landmark biomaterials research University of Chicago Retrieved June 14 2021 Jeffrey Hubbell recipient of the 2018 Acta Biomaterialia Gold Medal Materials Today November 3 2017 Retrieved June 14 2021 Jeffrey Hubbell named inaugural Bell Professor in Tissue Engineering University of Chicago June 15 2017 Retrieved June 14 2021 Jeffrey Hubbell named to National Academy of Medicine University of Chicago October 19 2018 Retrieved June 14 2021 Ayshford Emily February 1 2019 New vaccine for malaria developed at IME could be more effective University of Chicago Retrieved June 14 2021 Chicago Immunoengineering Innovation Center launches to develop technologies to treat diseases University of Chicago April 22 2020 Retrieved June 14 2021 Ayshford Emily April 30 2020 Breakthrough helps fight cold tumors that don t respond to immunotherapy University of Chicago Retrieved June 14 2021 Ayshford Emily October 12 2020 UChicago researchers find way to improve multiple sclerosis treatment University of Chicago Retrieved June 14 2021 Eight UChicago faculty elected to American Academy of Arts and Sciences University of Chicago April 23 2021 Retrieved June 14 2021 External links editJeffrey Hubbell publications indexed by Google Scholar Retrieved from https en wikipedia org w index php title Jeffrey Hubbell amp oldid 1177522936, wikipedia, wiki, book, books, library,
